Skip to content
Research Article Open access CC BY 3.0

Early or Selective Invasive Strategy in Patients with Non-ST-segment Elevation Acute Coronary Syndrome According to the Risk Factors at Presentation? An Outcome Study

Nikolay Dimitrov, Iana Simova, Boicho Boichev, Hristo Mateev

Cardiology and Angiology: An International Journal · pp. 205–222 · Published 9 Jun 2014

10.9734/CA/2014/10483

Abstract

Aims: Patients with acute coronary syndrome without ST segment elevation are a heterogeneous group with respect to the risk of having a major adverse cardiac event (MACE). History of diabetes mellitus (DM), chronic kidney disease (CKD) and elevated GRACE risk score are all factors defining a higher risk of MACE. We aimed to compare the outcome of patients with early vs selective invasive strategy according to the risk factors at presentation. Methodology: We enrolled 178 patients with unstable angina or non-ST elevation myocardial infarction (UA/NSTEMI), 52 (29.2%) had DM, 32 (19.7%)-CKD, defined when MDRD measured glomerular filtration rate (GFR) was <60ml/min/1.73m2 and 28 (15.7%) had GRACE≥140. The study had two arms: an early invasive strategy one (coronary arteriography and percutaneous coronary intervention within 24 hours after admission), and a selective invasive strategy arm (medical stabilization, with coronary arteriography required only in case of angina recurrence and/or evidence of inducible myocardial ischemia). Follow-up was 22.8±14 months. Results: For the whole group MACE occurred less often and the event free period was longer in the early invasive strategy group compared to selective invasive one (p=0.001). Early invasive strategy in diabetic patients, those with CKD and with GRACE ≥140 was associated with a reduced MACE rate (p=0.008, 0.016 and 0.006, respectively) and longer time to MACE occurrence compared with the selective invasive strategy. When we evaluated separately non-diabetics, patients with normal renal function and those with GRACE <140 we found no significant difference in MACE rate between the patients allocated to early invasive strategy and those assigned to selective invasive strategy. Early invasive strategy, however, showed some advantage over the selective one also in the subgroup analysis-the time to occurrence of MACE was prolonged in patients with lower risk at presentation. Conclusions: Early invasive strategy in UA/NSTEMI is associated with a reduced MACE rate and longer event-free period compared with selective invasive strategy. This benefit is clearly evident in higher risk subsets (patients with DM, CKD and GRACE ≥140).  

Non-ST-segment elevation acute coronary syndrome (NSTE-ACS) unstable angina (UA) non-ST elevation myocardial infarction (NSTEMI) early invasive strategy selective invasive strategy diabetes mellitus chronic kidney disease GRACE risk score

References (21)

  1. 1 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation [DOI]
  2. 2 Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study [DOI]
  3. 3 Predictors of Hospital Mortality in the Global Registry of Acute Coronary Events [DOI]
  4. 4 Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban [DOI]
  5. 5 Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction [DOI]
  6. 6 Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) [DOI]
  7. 7 A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS) [DOI]
  8. 8 Management of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE) [DOI]
  9. 9 Acute Myocardial Infarction and Renal Dysfunction: A High-Risk Combination [DOI]
  10. 10 Association of Renal Insufficiency with Treatment and Outcomes after Myocardial Infarction in Elderly Patients [DOI]
  11. 11 Evaluation of Prolonged Antithrombotic Pretreatment ("Cooling-Off" Strategy) Before Intervention in Patients With Unstable Coronary Syndromes [DOI]
  12. 12 “Renalism” [DOI]
  13. 13 Immediate vs Delayed Intervention for Acute Coronary Syndromes [DOI]
  14. 14 Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction [DOI]
  15. 15 Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non–ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature [DOI]
  16. 16 Chronic Kidney Disease in Patients with Non–ST-Segment Elevation Acute Coronary Syndromes [DOI]
  17. 17 Outcomes of Acute Coronary Syndrome in a Large Canadian Cohort: Impact of Chronic Renal Insufficiency, Cardiac Interventions, and Anemia [DOI]
  18. 18 Diabetes mellitus: clinical presentation and outcome in men and women with acute coronary syndromes. Data from the Euro Heart Survey ACS [DOI]
  19. 19 Cardiac biomarkers and acute coronary syndromes — The Euro Heart Survey of Acute Coronary Syndromes Experience [DOI]
  20. 20 Therapeutic Management in Patients with Renal Failure who Experience an Acute Coronary Syndrome [DOI]
  21. 21 Predictors of adverse outcome in a diabetic population following acute coronary syndromes.

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

59

Page views

0

PDF downloads

21

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.